TEDRA GRAY: Open Payments
NPI 1659358760 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35,043 in 132 payments from 16 companies in 2025. Trend: 2023 $7,445 · 2024 $23,822 · 2025 $35,043
Speaker / faculty: $21,309Travel & lodging: $5,485Consulting: $4,997Food & beverage: $3,174Education: $79
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 53 | $21,303 |
| Phathom Pharmaceuticals, Inc. | 8 | $4,116 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $3,821 |
| GENZYME CORPORATION | 5 | $2,239 |
| Regeneron Pharmaceuticals, Inc. | 2 | $1,434 |
| Ardelyx, Inc. | 8 | $749 |
| Janssen Biotech, Inc. | 13 | $428 |
| Madrigal Pharmaceuticals | 5 | $286 |
| ABBVIE INC. | 10 | $199 |
| Intercept Pharmaceuticals, Inc. | 2 | $137 |
Products named: DUPIXENT, VOQUEZNA, TRULANCE, IBSRELA, TREMFYA, REZDIFFRA, OCALIVA, RINVOQ.
Industry payments across IL — which companies pay providers there.
